Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05988411 · ClinicalTrials.gov registry record · NA

ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients

A NA study of Paroxysmal Atrial Fibrillation and Persistent Atrial Fibrillation, sponsored by Vivek Reddy.

Recruiting
Registry status
NA
Development phase
250
Enrollment target
8
Study locations

NCT05988411 is a NA study of Paroxysmal Atrial Fibrillation and Persistent Atrial Fibrillation that is actively recruiting participants, run by Vivek Reddy. The registered enrollment target is 250 participants, below the 849-participant average among 24 other Paroxysmal Atrial Fibrillation trials with a reported enrollment target (71% lower). The trial reports 8 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05988411, a NA study of Paroxysmal Atrial Fibrillation and Persistent Atrial Fibrillation, is actively recruiting participants, sponsored by Vivek Reddy.

RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
8
Study locations

Study Summary

This is a Prospective, controlled, single-blind, randomized (2:1, Intervention:Control) clinical trial. The purpose of the study is to determine the role of adjunctive renal sympathetic denervation in the prevention of Atrial Fibrillation (AF) recurrence in patients with hypertension scheduled for a redo AF ablation procedure for paroxysmal or persistent AF. Patients will be randomized to either i) AF ablation (Control) or ii) AF ablation + renal sympathetic denervation (Intervention).

Conditions Studied

Paroxysmal Atrial Fibrillation Persistent Atrial Fibrillation

Interventions

  • DEVICE Renal Denervation
  • DEVICE Catheter Ablation

Study Locations (8)

California

  • UCSF - San Francisco
  • Los Robles Medical Center - Thousand Oaks

Arkansas

  • Arrhythmia Research Group - Jonesboro

Michigan

  • Henry Ford Health System - Detroit

New York

  • Mount Sinai Hospital - New York

South Carolina

  • Trident Medical Center - Charleston

Texas

  • Christus - Tyler

Virginia

  • Virginia Commonwealth University - Richmond

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2023-12-07
Est. Completion 2027-12
Phase NA

Sponsor

Vivek Reddy

20 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05988411

The ClinicalTrials.gov registry entry for NCT05988411 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 849-participant average among 24 other Paroxysmal Atrial Fibrillation trials with a reported enrollment target (71% lower). The listed sponsor is Vivek Reddy, which has 20 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Paroxysmal Atrial Fibrillation appearing as the primary indexed condition, and to 2 interventions - of which Renal Denervation is the first listed.

NCT05988411 reports 8 study locations spanning 7 distinct geographic areas - top geographies include California, Arkansas, Michigan.

Frequently Asked Questions

What is clinical trial NCT05988411 about?

NCT05988411 is a clinical study titled "ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients". This is a Prospective, controlled, single-blind, randomized (2:1, Intervention:Control) clinical trial. The purpose of the study is to determine the role of adjunctive renal sympathetic denervation in the prevention of Atrial Fibrillation (AF) recurrence in patients with hypertension scheduled for a...

What is the current status of trial NCT05988411?

This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2023-12-07. Estimated completion is 2027-12.

What conditions does trial NCT05988411 study?

This clinical trial studies the following conditions: Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation.

What interventions are being tested in trial NCT05988411?

The interventions under investigation include: Renal Denervation (DEVICE), Catheter Ablation (DEVICE).

Who is sponsoring clinical trial NCT05988411?

This trial is sponsored by Vivek Reddy, which has 20 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05988411 being conducted?

This trial has 8 study locations across Arkansas, California, Michigan, New York, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Paroxysmal Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Paroxysmal Atrial Fibrillation

All registered trials for this condition

Persistent Atrial Fibrillation

All registered trials for this condition

Arkansas

All trials with a study site in Arkansas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.